Urovant Sciences Ltd.

04/12/2021 | Press release | Distributed by Public on 04/12/2021 06:23

Urovant Sciences Announces U.S. Commercial Launch of GEMTESA® (vibegron) 75 mg Tablets for Patients with Overactive Bladder